Development of new malaria diagnostics: matching performance and need

Area of Science:

• Global Health
• Medical Diagnostics
• Parasitology

Background:

• Significant gaps persist in accessing accurate malaria diagnosis, leading to resource waste and poor disease management, particularly in low-resourced settings.
• Despite substantial investment, few novel malaria diagnostic technologies have been introduced in the last 30 years, indicating potential misdirection in development efforts or barriers to adoption.
• The malaria diagnostic market is complex, influenced by donor dependency, weak health systems, and evolving program priorities, hindering the successful introduction of new tools.

Discussion:

• Development efforts for malaria diagnostics need to align with specific market requirements to improve product development funding outcomes.
• Six distinct market segments for malaria diagnostics are identified, ranging from case management in resource-limited areas to surveillance and clinical research.
• The variable market sizes and evolving nature of malaria epidemiology necessitate a clear understanding of program gaps and market sustainability.

Key Insights:

• Successful malaria diagnostic development requires a strategic approach, focusing on clearly defined market needs and segments.
• Addressing fundamental blocks to technology introduction is essential for improving access to accurate malaria diagnosis.
• Collaboration among diverse stakeholders is vital for the successful introduction and scaling of new diagnostic technologies.

Outlook:

• Future success in malaria diagnostics hinges on innovative business models and potential donor involvement to overcome economic challenges.
• Targeting assay development to specific, well-defined market requirements will enhance the impact of R&D funding.
• A concerted effort involving stakeholders is necessary to ensure the widespread adoption and scaling of new malaria diagnostic solutions.